AzTrials
AzTrials

Specialty

Infectious diseases clinical trials

Trials of vaccines and treatments for HIV, COVID-19, influenza, hepatitis, tuberculosis, malaria and other infections.

6,190 open to volunteers, 56,403 registered in all

About infectious diseases research

Infectious disease studies include vaccine trials in healthy volunteers, antiviral and antibiotic treatments, and prevention studies. Many run in several countries at once.

Research areas

Open trials in each area. Counts come from the latest copy of the registry.

Recently updated open trials

Studies looking for volunteers, most recently updated by their sponsors first.

All 6,190 open trials
  • Mycobacterium Infections, Tuberculosis, Multidrug-Resistant

    Training Protocol on the Natural History of Tuberculosis

    • Recruiting
    • Age: 2 to 100 years
    • Observational study

    Background: Tuberculosis (TB) is an infectious disease that affects numerous people worldwide. Researchers are interested in actively recruiting individuals with TB for research and treatment studies.

    Conditions
    Mycobacterium Infections, Tuberculosis, Multidrug-Resistant, Latent Tuberculosis, Tuberculosis
    Trial name
    NCT01212003
    Where
    United States
    Volunteers
    150 people
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Can I take part? NCT01212003
  • Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis

    A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis

    • Recruiting
    • Age: 14 years and older
    • Phase 3

    This is a Phase 3, randomized, open-label, active-controlled, multicenter trial evaluating the efficacy, safety, and tolerability of quabodepistat-containing regimens for the treatment of rifampicin-resistant or…

    Trial name
    QUANTUM-TB (NCT07209761)
    Testing
    Bedaquiline, Quabodepistat, Pretomanid
    Where
    42 sites in China, Georgia and 8 more
    Volunteers
    532 people
    Sponsor
    Otsuka Pharmaceutical Development & Commercialization, Inc.
    Can I take part? QUANTUM-TB
  • Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia

    A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia

    • Not yet recruiting
    • Age: 6 months to 17 years
    • Phase 1/2

    The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescents with acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) that has come back after treatment…

    Conditions
    Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, Pediatric Cancer
    Trial name
    NCT07770698
    Testing
    sonrotoclax, Azacitidine, Inotuzumab ozogamicin
    Volunteers
    30 people
    Sponsor
    BeOne Medicines
    Can I take part? NCT07770698
  • Vaccination, Respiratory Syncytial Virus (RSV)

    Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients

    • Recruiting
    • Age: 19 years and older
    • Phase 4
    • Vaccines

    The purpose of this study is to compare the immunogenicity and safety of respiratory syncytial virus (RSV) vaccination between lung transplant recipients and immunocompetent adults and to provide evidence to guide RSV vaccination…

    Conditions
    Vaccination, Respiratory Syncytial Virus (RSV), Lung Transplant Recipient
    Trial name
    NCT07895394
    Testing
    RSVPreF3 vaccination
    Where
    South Korea
    Volunteers
    80 people
    Sponsor
    Seoul National University Hospital
    Can I take part? NCT07895394
  • Pneumococcal Disease

    A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants

    • Recruiting
    • Age: 42 to 98 days
    • Phase 3
    • Vaccines

    The purpose of this study is to learn about the safety of a new pneumococcal vaccine and how the new pneumococcal vaccine helps to fight against germs that can cause pneumonia (lung infections), meningitis (brain infections), and…

    Trial name
    NCT07573462
    Testing
    PG4, 20-valent pneumococcal conjugate vaccine (20vPnC)
    Where
    78 sites in United States, Argentina and 8 more
    Volunteers
    2,400 people, healthy volunteers welcome
    Sponsor
    Pfizer
    Can I take part? NCT07573462
  • Healthy Volunteer, Malaria

    Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection

    • Not yet recruiting
    • Age: 18 to 54 years

    Background: Malaria is a serious disease caused by parasites spread by mosquitoes. To better diagnose and treat malaria, researchers need to learn more about where the parasites go when they enter a person's body.

    Trial name
    NCT07859800
    Testing
    18F-fluorodeoxyglucose-positron emission tomography/computed tomography scan
    Where
    United States
    Volunteers
    45 people
    Sponsor
    National Institute of Allergy and Infectious Diseases (NIAID)
    Can I take part? NCT07859800
  • HIV, Pregnancy

    Evaluating the Healthy Families PrEP Program for Women at Risk for HIV

    • Not yet recruiting
    • Age: 18 to 45 years

    Study investigators developed and piloted a counselling intervention, Healthy Families-PrEP, that supports women to use HIV prevention strategies while trying for and during pregnancy.

    Conditions
    HIV, Pregnancy, Pre-Exposure Prophylaxis of HIV Infection
    Trial name
    HFPT (NCT06746675)
    Testing
    Healthy Families PrEP Counselling Intervention
    Where
    Uganda
    Volunteers
    660 people, healthy volunteers welcome
    Sponsor
    Yale University
    Can I take part? HFPT
  • Leukocyte Disorders, Respiratory Tract Diseases

    Collection of Lung Fluid and Tissue Samples for Research

    • Recruiting
    • Age: 5 to 100 years
    • Observational study

    This study will collect fluid and tissue specimens from the lungs and nose of healthy people and people with a history of lung infections.

    Conditions
    Leukocyte Disorders, Respiratory Tract Diseases, Bronchoscopy
    Trial name
    NCT00471250
    Where
    United States
    Volunteers
    550 people, healthy volunteers welcome
    Sponsor
    National Heart, Lung, and Blood Institute (NHLBI)
    Can I take part? NCT00471250

Narrow the search

Conditions in infectious diseases

Conditions with their own page on AzTrials, with the number of registered studies.

Questions about infectious diseases trials

Which trials are counted as infectious diseases?

Studies whose conditions, or the medical subject headings the registry adds to them, mention any of these terms: hiv, covid, influenza, hepatitis, tuberculosis, malaria, infection, sepsis, pneumococcal, rsv. A study can belong to more than one specialty, and the grouping is AzTrials', not the sponsor's.

Are all of these trials recruiting?

No. The lists on this page show studies open to volunteers (recruiting, not yet recruiting or enrolling by invitation), as the sponsor last reported. The full search also includes completed and stopped studies, some with posted results.

How can I refer a patient to one of these trials?

Open the trial and use the contacts and sites it lists; the For doctors view of each trial collects them with the key eligibility criteria. AzTrials does not enrol participants or take referrals.

Other specialties

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in